Fibroblast growth factor 23 (FGF23) is elevated in CKD; it disturbs the immune defence by inhibiting chemokine-activated leucocytes to adhere through integrins to endothelia, and blocks the transendothelial migration of neutrophil leucocytes [37]. This evidence concerns the gene FGF23 and chronic kidney disease.